CCND1 and prostate carcinoma: In addition, the cyclin D1 downregulation by TY-NS-B was observed in human breast cancer cells (MDA-MB-231), human pancreatic cancer cells (AsPC-1), human non-small cell lung cancer cells (A549) and human prostate cancer cells (PC-3).